| abstract |
【Task】 A therapeutically effective amount of exendin, a thickener, methyl-β-cyclodextrin, a surfactant, a tartrate buffer for pH adjustment and a cationic chelator, and depending on the exendin dosage form A pharmaceutical formulation for intranasal administration of exendin to a mammal is described that exhibits at least 95% exenatide recovery after storage for at least 365 days at 5 ° C. [Selection figure] None |